F782-1319 Screening compound: N-(2-benzamido-1,3-benzothiazol-5-yl)-1H,4H-chromeno[4,3-c]pyrazole-3-carboxamide

F782-1319 Screening compound: N-(2-benzamido-1,3-benzothiazol-5-yl)-1H,4H-chromeno[4,3-c]pyrazole-3-carboxamide
F782-1319 Screening compound: N-(2-benzamido-1,3-benzothiazol-5-yl)-1H,4H-chromeno[4,3-c]pyrazole-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F782-1319
N-(2-benzamido-1,3-benzothiazol-5-yl)-1H,4H-chromeno[4,3-c]pyrazole-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F782-1319

Molecular Formula

C25H17N5O3S (C25 H17 N5 O3 S)

Compound Name

N-(2-benzamido-1,3-benzothiazol-5-yl)-1H,4H-chromeno[4,3-c]pyrazole-3-carboxamide

IUPAC name

N-(2-benzamido-13-benzothiazol-5-yl)-1H4H-chromeno[43-c]pyrazole-3-carboxamide

SMILES

O=C(c1n[nH]c-2c1COc1c2cccc1)Nc(cc1)cc2c1sc(NC(c1ccccc1)=O)n2

InChI

InChI=1S/C25H17N5O3S/c31-23(14-6-2-1-3-7-14)28-25-27-18-12-15(10-11-20(18)34-25)26-24(32)22-17-13-33-19-9-5-4-8-16(19)21(17)29-30-22/h1-12H,13H2,(H,26,32)(H,29,30)(H,27,28,31)

InChI Key

AKWRGGURXQJQMD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14966512

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

467.51

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.900

Distribution Coefficient, logD

4.897

Water Solubility, LogSw

-4.86

Polar Surface Area

88.674

Acid Dissociation Constant (pKa)

9.62

Base Dissociation Constant (pKb)

-1.49

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

4.00

F782-1319 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Inflammatory Library (24602 compounds)

Antiviral Library (67538 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F782-1319 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F782-1319?
Check Price and Availability of F782-1319, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F782-1319 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F782-1319
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F782-1319
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F782-1319 available by request